Log In
BCIQ
Print this Print this
 

KPT-276

  Manage Alerts
Collapse Summary General Information
Company Karyopharm Therapeutics Inc.
DescriptionCRM1 inhibtor
Molecular Target Exportin 1 (XPO1) (CRM1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat multiple myeloma (MM)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today